181 related articles for article (PubMed ID: 2677141)
1. Dual role of the CD44 molecule in T cell adhesion and activation.
Shimizu Y; Van Seventer GA; Siraganian R; Wahl L; Shaw S
J Immunol; 1989 Oct; 143(8):2457-63. PubMed ID: 2677141
[TBL] [Abstract][Full Text] [Related]
2. Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44.
Rothman BL; Blue ML; Kelley KA; Wunderlich D; Mierz DV; Aune TM
J Immunol; 1991 Oct; 147(8):2493-9. PubMed ID: 1833455
[TBL] [Abstract][Full Text] [Related]
3. CD44 contributes to T cell activation.
Huet S; Groux H; Caillou B; Valentin H; Prieur AM; Bernard A
J Immunol; 1989 Aug; 143(3):798-801. PubMed ID: 2568380
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation.
Denning SM; Le PT; Singer KH; Haynes BF
J Immunol; 1990 Jan; 144(1):7-15. PubMed ID: 1967267
[TBL] [Abstract][Full Text] [Related]
5. A unique CD44 monoclonal antibody identifies a new T cell activation pathway.
Pierres A; Lipcey C; Mawas C; Olive D
Eur J Immunol; 1992 Feb; 22(2):413-7. PubMed ID: 1347013
[TBL] [Abstract][Full Text] [Related]
6. CD44 antibody against In(Lu)-related p80, lymphocyte-homing receptor molecule inhibits the binding of human erythrocytes to T cells.
Hale LP; Singer KH; Haynes BF
J Immunol; 1989 Dec; 143(12):3944-8. PubMed ID: 2480381
[TBL] [Abstract][Full Text] [Related]
7. Human T lymphocyte adhesion to endothelial cells and transendothelial migration. Alteration of receptor use relates to the activation status of both the T cell and the endothelial cell.
Oppenheimer-Marks N; Davis LS; Lipsky PE
J Immunol; 1990 Jul; 145(1):140-8. PubMed ID: 1972715
[TBL] [Abstract][Full Text] [Related]
8. Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway.
Koopman G; van Kooyk Y; de Graaff M; Meyer CJ; Figdor CG; Pals ST
J Immunol; 1990 Dec; 145(11):3589-93. PubMed ID: 2246503
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to CD44 trigger effector functions of human T cell clones.
Galandrini R; Albi N; Tripodi G; Zarcone D; Terenzi A; Moretta A; Grossi CE; Velardi A
J Immunol; 1993 May; 150(10):4225-35. PubMed ID: 8097750
[TBL] [Abstract][Full Text] [Related]
10. A 19-kDa human erythrocyte molecule H19 is involved in rosettes, present on nucleated cells, and required for T cell activation. Comparison of the roles of H19 and LFA-3 molecules in T cell activation.
Groux H; Huet S; Aubrit F; Tran HC; Boumsell L; Bernard A
J Immunol; 1989 May; 142(9):3013-20. PubMed ID: 2468708
[TBL] [Abstract][Full Text] [Related]
11. Anti-T12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes.
Gangemi RM; Swack JA; Gaviria DM; Romain PL
J Immunol; 1989 Oct; 143(8):2439-47. PubMed ID: 2794503
[TBL] [Abstract][Full Text] [Related]
12. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A
Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
Guo YJ; Ma J; Wong JH; Lin SC; Chang HC; Bigby M; Sy MS
Cell Immunol; 1993 Nov; 152(1):186-99. PubMed ID: 7694807
[TBL] [Abstract][Full Text] [Related]
14. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
15. Elevation of intracellular cAMP in human T lymphocytes by an anti-CD44 mAb.
Rothman BL; Kennure N; Kelley KA; Katz M; Aune TM
J Immunol; 1993 Dec; 151(11):6036-42. PubMed ID: 7504012
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells.
Galandrini R; Galluzzo E; Albi N; Grossi CE; Velardi A
J Immunol; 1994 Jul; 153(1):21-31. PubMed ID: 7515923
[TBL] [Abstract][Full Text] [Related]
17. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
18. Enhancing effect of anti-HLA class I monoclonal antibodies on T cell proliferation induced via CD2 molecule.
Turco MC; de Felice M; Corbo L; Giarrusso PC; Yang SY; Ferrone S; Venuta S
J Immunol; 1988 Oct; 141(7):2275-81. PubMed ID: 3262654
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the tyrosine kinase-dependent adhesion pathway in human lymphocytes through CD45.
Wagner N; Engel P; Tedder TF
J Immunol; 1993 Jun; 150(11):4887-99. PubMed ID: 7684415
[TBL] [Abstract][Full Text] [Related]
20. Effects of anti-CD44 monoclonal antibody on adhesion of erythroid leukemic cells (ELM-I-1) to hematopoietic supportive cells (MS-5): CD44, but not hyaluronate-mediated, cell-cell adhesion.
Sugimoto K; Tsurumaki Y; Hoshi H; Kadowaki S; LeBousse-Kerdiles MC; Smadja-Joffe F; Mori KJ
Exp Hematol; 1994 Jun; 22(6):488-94. PubMed ID: 7514542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]